APA (7th ed.) Citation

G, Z., D, F., X, L., S, D., J, M. W., A, H., . . . SH, L. (2019). Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer. Scientific reports, 9(1), 16735. https://doi.org/10.1038/s41598-019-53130-4

Chicago Style (17th ed.) Citation

G, Zhu, et al. "Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer." Scientific Reports 9, no. 1 (2019): 16735. https://doi.org/10.1038/s41598-019-53130-4.

MLA (9th ed.) Citation

G, Zhu, et al. "Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer." Scientific Reports, vol. 9, no. 1, 2019, p. 16735, https://doi.org/10.1038/s41598-019-53130-4.